Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Sumi B"'
Publikováno v:
Nigerian Journal of Paediatrics, Vol 41, Iss 1, Pp 1-6 (2024)
Background:Monitoring response to highly active antiretroviral therapy (HAART) in HIV infected children using both laboratory and physical growth parameter is important. But monitoring laboratory parameters could sometimes be challenging in resource
Externí odkaz:
https://doaj.org/article/adafa06f91e544739ba2ccc18cc47982
Autor:
Kuang-Ting Ko, Frank Lennartz, David Mekhaiel, Bora Guloglu, Arianna Marini, Danielle J. Deuker, Carole A. Long, Matthijs M. Jore, Kazutoyo Miura, Sumi Biswas, Matthew K. Higgins
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-11 (2022)
Pfs48/45, a surface protein of Plasmodium falciparum, is a promising anti-malarial vaccine candidate whose structure is not entirely resolved. Here, the authors present the structure of the full-length molecule, and characterise the binding and activ
Externí odkaz:
https://doaj.org/article/1355932f57d3418087395ce9a33cabbe
Autor:
Matthew J. Broadhead, Calum Bonthron, Lauren Arcinas, Sumi Bez, Fei Zhu, Frances Goff, Jonathan Nylk, Kishan Dholakia, Frank Gunn-Moore, Seth G. N. Grant, Gareth B. Miles
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-3 (2021)
Externí odkaz:
https://doaj.org/article/63c88a95eb4f46b78445ad9becf78b92
Autor:
Hidetsugu Fujigaki, Yasuko Yamamoto, Takenao Koseki, Sumi Banno, Tatsuya Ando, Hiroyasu Ito, Takashi Fujita, Hiroyuki Naruse, Tadayoshi Hata, Saya Moriyama, Yoshimasa Takahashi, Tadaki Suzuki, Takahiro Murakami, Yukihiro Yoshida, Yo Yagura, Takayoshi Oyamada, Masao Takemura, Masashi Kondo, Mitsunaga Iwata, Kuniaki Saito
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 1 (2022)
ABSTRACT To fight severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), mass vaccination has begun in many countries. To investigate the usefulness of a serological assay to predict vaccine ef
Externí odkaz:
https://doaj.org/article/02f37115e02d48b4a436a03cac1f74b1
Autor:
Angela M. Minassian, Yrene Themistocleous, Sarah E. Silk, Jordan R. Barrett, Alison Kemp, Doris Quinkert, Carolyn M. Nielsen, Nick J. Edwards, Thomas A. Rawlinson, Fernando Ramos Lopez, Wanlapa Roobsoong, Katherine J.D. Ellis, Jee-Sun Cho, Eerik Aunin, Thomas D. Otto, Adam J. Reid, Florian A. Bach, Geneviève M.C. Labbé, Ian D. Poulton, Arianna Marini, Marija Zaric, Margaux Mulatier, Raquel Lopez Ramon, Megan Baker, Celia H. Mitton, Jason C. Sousa, Nattawan Rachaphaew, Chalermpon Kumpitak, Nongnuj Maneechai, Chayanut Suansomjit, Tianrat Piteekan, Mimi M. Hou, Baktash Khozoee, Kirsty McHugh, David J. Roberts, Alison M. Lawrie, Andrew M. Blagborough, Fay L. Nugent, Iona J. Taylor, Kimberly J. Johnson, Philip J. Spence, Jetsumon Sattabongkot, Sumi Biswas, Julian C. Rayner, Simon J. Draper
Publikováno v:
JCI Insight, Vol 6, Iss 23 (2021)
Controlled human malaria infection (CHMI) provides a highly informative means to investigate host-pathogen interactions and enable in vivo proof-of-concept efficacy testing of new drugs and vaccines. However, unlike Plasmodium falciparum, well-charac
Externí odkaz:
https://doaj.org/article/8f5efdb3fb3a46f088a6c09f41c0d102
Autor:
Marija Zaric, Arianna Marini, Carolyn M. Nielsen, Gaurav Gupta, David Mekhaiel, Thao P. Pham, Sean C. Elias, Iona J. Taylor, Hans de Graaf, Ruth O. Payne, Yuanyuan Li, Sarah E. Silk, Chris Williams, Adrian V. S. Hill, Carole A. Long, Kazutoyo Miura, Sumi Biswas
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Plasmodium falciparum transmission-blocking vaccines (TBVs) targeting the Pfs25 antigen have shown promise in mice but the same efficacy has never been achieved in humans. We have previously published pre-clinical data related to a TBV candidate Pfs2
Externí odkaz:
https://doaj.org/article/f21e9455de774a698a42b7af607f559b
Autor:
Hans de Graaf, Ruth O. Payne, Iona Taylor, Kazutoyo Miura, Carol A. Long, Sean C. Elias, Marija Zaric, Angela M. Minassian, Sarah E. Silk, Lee Li, Ian D. Poulton, Megan Baker, Simon J. Draper, Diane Gbesemete, Nathan J. Brendish, Filipa Martins, Arianna Marini, David Mekhaiel, Nick J. Edwards, Rachel Roberts, Johan Vekemans, Sarah Moyle, Saul N. Faust, Eleanor Berrie, Alison M. Lawrie, Fergal Hill, Adrian V. S. Hill, Sumi Biswas
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
BackgroundTransmission blocking vaccines targeting the sexual-stages of the malaria parasite could play a major role to achieve elimination and eradication of malaria. The Plasmodium falciparum Pfs25 protein (Pfs25) is the most clinically advanced ca
Externí odkaz:
https://doaj.org/article/daf9bdd8e4a1400a9c2b0c0584c0a152
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Daniel Wright, Elizabeth R. Allen, Madeleine H.A. Clark, John N. Gitonga, Henry K. Karanja, Ruben J.G. Hulswit, Iona Taylor, Sumi Biswas, Jennifer Marshall, Damaris Mwololo, John Muriuki, Bernard Bett, Thomas A. Bowden, George M. Warimwe
Publikováno v:
iScience, Vol 23, Iss 11, Pp 101669- (2020)
Summary: Rift Valley fever (RVF) is a viral hemorrhagic disease first discovered in Kenya in 1930. Numerous animal studies have demonstrated that protective immunity is acquired following RVF virus (RVFV) infection and that this correlates with acqui
Externí odkaz:
https://doaj.org/article/a0c1c18735e34b9c8e2bc08665f601f0
Autor:
Frank Lennartz, Florian Brod, Rebecca Dabbs, Kazutoyo Miura, David Mekhaiel, Arianna Marini, Matthijs M. Jore, Max M. Søgaard, Thomas Jørgensen, Willem A. de Jongh, Robert W. Sauerwein, Carole A. Long, Sumi Biswas, Matthew K. Higgins
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-11 (2018)
Pfs48/45 is a promising component for a transmission-blocking malaria vaccine. Here, the authors develop a system to produce full-length Pfs48/45 for immunisation, characterise a panel of monoclonal antibodies and determine the structure of a potent
Externí odkaz:
https://doaj.org/article/3e590003190943eebd4a943c9cadaa5a